CL vs LIN
Colgate-palmolive Company and Linde PLC, side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | CL | LIN |
|---|---|---|
| Revenue | $20.4B | $34.0B |
| Net income | $2.1B | $6.9B |
| Gross margin | 60.1% | — |
| Net margin | 10.5% | 20.3% |
| Return on equity | 1603.0% | 18.1% |
| Diluted EPS | $2.63 | $14.61 |
| Dividend / share | $2.08 | $6.00 |
| Payout ratio | — | 40.8% |
| Free cash flow | $3.6B | $5.1B |
| Equity | $54.0M | $38.2B |
| Net debt / equity | 124.04× | 0.46× |
| Current ratio | 0.83× | 0.88× |
| Revenue CAGR 5y | 4.4% | 4.5% |
| Profit CAGR 5y | −4.6% | 22.5% |
LIN bills 1.7× the revenue of CL, and keeps more of each dollar of revenue as profit (20.3% against 10.5%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | CL | LIN |
|---|---|---|
| FY2025 | $20.4B | $34.0B |
| FY2024 | $20.1B | $33.0B |
| FY2023 | $19.5B | $32.9B |
| FY2022 | $18.0B | $33.4B |
| FY2021 | $17.4B | $30.8B |
| FY2020 | $16.5B | $27.2B |
| FY2019 | $15.7B | $28.2B |
| FY2018 | $15.5B | $14.8B |
| FY2017 | $15.5B | $11.4B |
| FY2016 | $15.2B | $10.5B |
Net income by year
Bottom line
| Fiscal year | CL | LIN |
|---|---|---|
| FY2025 | $2.1B | $6.9B |
| FY2024 | $2.9B | $6.6B |
| FY2023 | $2.3B | $6.2B |
| FY2022 | $1.8B | $4.1B |
| FY2021 | $2.2B | $3.8B |
| FY2020 | $2.7B | $2.5B |
| FY2019 | $2.4B | $2.3B |
| FY2018 | $2.4B | $4.4B |
| FY2017 | $2.0B | $1.2B |
| FY2016 | $2.4B | $1.5B |
Advertisement
AdSense · Rectangle 336×280